The page you were trying to view does not exists or may have expired. Below are the list of similar positions in our database.
Similar Posts
-
We have an exciting opportunity for a Project Administrator to join the Oxford Trauma group at the Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, to be based
-
immune challenge being conducted in Oxford and led by A/Prof James Fullerton Associate Professor of Clinical Therapeutics, NDORMS, University of Oxford which is based at the Botnar Research Centre
-
Pay Scale: STANDARD GRADE 8 Salary (£): £45,585 - £54,395 per annum Location: Oxford Respiratory Trials Unit, Churchill Hospital Contract Type: Fixed-Term Hours: Full-Time About the Role We
-
We are looking for a Clinical Trial Manager to join the Experimental Medicine and Rheumatology (EMR) trials groups within the UKCRC accredited Oxford Clinical Trials Research Unit (OCTRU) based in
-
TB, malaria, hepatitis C virus, HIV, Ebola, influenza, emerging and outbreak pathogens, and prostate cancer. You will be liasing with colleagues across NDM, other clinical trial units in the University
-
Research Centre, NDORMS, University of Oxford. Welcome to the Planetary Health Informatics Group. We combine fair and safe artificial intelligence, remote monitoring technology and clinical epidemiology
-
/Prof James Fullerton Associate Professor of Clinical Therapeutics, NDORMS, University of Oxford which is based at the Botnar Research Centre. These tend to involve healthy volunteers, be of small size
-
informed consent to participate in specific studies, and ensuring the safe administration of treatments and drugs in line with the study protocols. You will also perform clinical procedures including
-
management for randomised controlled trials on the NPEU CTU portfolio. This is a great opportunity to join a friendly, supportive team with scope to contribute to wider development work of the Clinical Trials
-
of experience in vaccine research, the Oxford Vaccine Group undertakes vaccine research at all stages of the process from pre-clinical development to late phase policy influencing trials, with the sole aim